| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |